Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
MediWound Ltd. (NASDAQ: MDWD)
MDWD Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
26%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
154.90%
MDWD Stock Analysis
MDWD
PE Ratio:
MDWD
PEG Ratio:
Not Available
MDWD
Forward EPS Growth (12 month):
0.00%
MDWD
PS Ratio:
10.3
MDWD
PSG Ratio:
0.3
MDWD
Forward Revenue Growth (12 month):
35.00%
MDWD Articles
No data was found